ROCKET COS INC-CLASS A (RKT)       9.27  -0.09 (-0.96%)

9.27  -0.09 (-0.96%)

US77311W1018 - Common Stock - After market: 9.21 -0.06 (-0.65%)


Fundamental Rating

2

We assign a fundamental rating of 2 out of 10 to RKT. RKT was compared to 74 industry peers in the Thrifts & Mortgage Finance industry. RKT has a medium profitability rating, but doesn't score so well on its financial health evaluation. RKT has a expensive valuation and it also scores bad on growth




Profitability

Profitability Rating

4

RKT's Return On Equity of 20.08% is amongst the best returns of the industry. RKT outperforms 89% of its industry peers. The industry average return on equity is 10.57%.
The Piotroski-F score of RKT is 4.00. This is a neutral score and indicates average health and profitability for RKT.

RKT has a Return On Assets of 0.50%. This is below the industry average of 1.40%. 90% of the industry peers outperform RKT.
RKT's Profit Margin of 1.38% is worse than the rest of the industry. The industry average Profit Margin is 35.21%. 100% of the industry peers have a better Profit Margin.
VS Industry

ROA (0.5%) VS Industry: 10% outperformed.

0.17
15.57

ROE (20.08%) VS Industry: 89% outperformed.

0.59
41.47

Profit Margin (1.38%) VS Industry: 0% outperformed.

1.38
84.17

Valuation

Valuation Rating

2

Compared to an average Enterprise Value to EBITDA ratio of 5.40, RKT is valued rather cheaply. On top of this, RKT has a better ratio than 93% of the companies listed in the same industry.
When comparing the current price to the book value of RKT, we can conclude it is valued correctly. It is trading at 2.02 times its book value.
With a Price/Earnings Ratio of 25.75, RKT can be considered very expensive at the moment.

Compared to an average industry Price/Earning Ratio of 11.46, RKT is valued slightly more expensive.
With a Forward Price/Earnings Ratio of 404.86, RKT is valued very expensively.
Compared to an average industry price book ratio of 1.02, RKT is valued more expensive than its industry peers.
VS Industry

Price/Earnings (25.75) VS Industry: 26% outperformed.

143.84
0.03

Price/Book (2.02) VS Industry: 23% outperformed.

11.92
0.01

Enterprise Value/ EBITDA (1.47) VS Industry: 93% outperformed.

156.85
0.80

Growth

Growth Rating

2

The EPS growth is accelerating: in the next 5 years the growth will be better than in the last years.
RKT shows a strong growth in Revenue. Measured over the last 5 years, the Revenue has been growing by 21.94% yearly.
RKT is expected to show a decrease in Earnings Per Share. In the coming 5 years, the EPS will decrease by -8.02% yearly.
RKT is expected to show a decrease in Revenue. In the coming 5 years, the Revenue will decrease by -0.53% yearly.

The earnings per share for RKT have decreased strongly by -88.24% in the last year.
The earnings per share for RKT have been decreasing by -61.40% on average. This is quite bad
The Revenue for RKT has decreased by -59.23% in the past year. This is quite bad
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming 5 years, we see that the growth is decreasing.

PastFuture
5Y3Y1Y1Y2Y3Y5Y
EPS-61.4% N/A -88.24% -103.96% -89.89% -37.98% -8.02%
Revenue21.94% 45.14% -59.23% -52.06% -42.72% -23.89% -0.53%

Health

Health Rating

1

RKT has a Piotroski-F score of 4.00. This indicates an average health and profitability for RKT.
RKT has a Current Ratio of 0.11. This is a bad value and indicates that RKT is not financially healthy enough and could expect problems in meeting its short term obligations.
Compared to an average industry Current Ratio of 0.22, RKT is worse placed to pay its short term obligations than its industry peers. 88% of its industry peers have a better Current Ratio.
RKT has a Quick Ratio of 0.11. This is a bad value and indicates that RKT is not financially healthy enough and could expect problems in meeting its short term obligations.

Compared to an average industry Quick Ratio of 0.22, RKT is worse placed to pay its short term obligations than its industry peers. 88% of its industry peers have a better Quick Ratio.
RKT has one of the worst Debt to Equity ratios in its industry. 91% of its industry peers require less debt for financing their operations.
RKT has an Altman-Z score of 0.46. This is a bad value and indicates that RKT is not financially healthy and even has some risk of bankruptcy.
When comparing the Altman-Z score of RKT to the average industry Altman-Z score of 1.08, RKT is less financially healthy than its industry peers.
VS Industry

Debt/Equity (7.25) VS Industry: 9% outperformed.

55.93
0.00

Quick Ratio (0.11) VS Industry: 12% outperformed.

0.02
8.78

Current Ratio (0.11) VS Industry: 12% outperformed.

0.02
8.78

Altman-Z (0.46) VS Industry: 31% outperformed.

-20.07
8.73

Dividend

Dividend Rating

0

No dividends for RKT!.

ROCKET COS INC-CLASS A9.27

NYSE:RKT (1/30/2023, 7:18:52 PM)-0.09 (-0.96%)

After market: 9.21 -0.06 (-0.65%)

Chartmill FA Rating
GICS Sector Financials
GICS IndustryGroup Banks
GICS Industry Thrifts & Mortgage Finance
Earnings (Last) 11-03 2022-11-03/amc Earnings (Next) 02-22 2023-02-22
Inst Owners 64.59% Inst Owner Change -0.35%
Ins Owners 6.89% Ins Owner Change 34.71%
Market Cap 1.13B Analysts 52.17
Price Target 7.47 (-19.42%)

Dividend
Dividend Yield N/A Dividend Growth N/A
DP N/A Ex-Date N/A

Surprises & Revisions
EPS beat(2) N/A Avg EPS beat(2) -214.78%
Min EPS beat(2) -237.7% Max EPS beat(2) -191.85%
EPS beat(4) N/A Avg EPS beat(4) -115.76%
Min EPS beat(4) -237.7% Max EPS beat(4) -13.3%
Revenue beat(2) 1 Avg Revenue beat(2) 8.86%
Min Revenue beat(2) -4.39% Max Revenue beat(2) 22.12%
Revenue beat(4) 2 Avg Revenue beat(4) 9.78%
Min Revenue beat(4) -4.39% Max Revenue beat(4) 22.12%
PT rev (1m) 2.83% EPS NQ rev (1m) 0%
EPS NY rev (1m) 0% Revenue NQ rev (1m) 0%
Revenue NY rev (1m) 0%

Valuation
Industry RankSector Rank
PE 25.75
Fwd PE 404.86
P/S 0.14
P/FCF 0.08
P/OCF 0.08
P/B 2.02
P/tB N/A
EV/EBITDA 1.47
EPS(TTM) 0.36 EY 3.88%
EPS(NY) 0.02 Fwd EY 0.25%
FCF(TTM) 114.17 FCFY 1231.64%
OCF(TTM) 115.06 OCFY 1241.19%
SpS 66.82 BVpS 4.59
TBVpS -55.03 PEG (NY) N/A
PEG (5Y) N/A

Profitability
Industry RankSector Rank
ROA 0.5%
ROE 20.08%
ROIC 10.31%
ROICexc 10.71%
ROICexgc 20.22%
OM 35.19%
PM 1.38%
GM N/A
ROICexgc(3y) 20.6% ROICexcg growth 3Y 27.98%
ROICexcg growth 5Y N/A ROICexc(3y) 16.64%
ROICexc growth 3Y 34.01% ROICexc growth 5Y N/A
OM growth 3Y 31.23% OM growth 5Y 4.92%
PM growth 3Y N/A PM growth 5Y -42.43%
GM growth 3Y N/A GM growth 5Y N/A
F-Score 4 Asset Turnover 0.36

Health
Industry RankSector Rank
Debt/Equity 7.25
Debt/FCF 0.81
Debt/EBITDA 3.81
Cap/Depr 120.64%
Profit Quality 12399.4%
Current Ratio 0.11
Quick Ratio 0.11
Altman-Z 0.46
F-Score 4 WACC 2.01%
ROIC/WACC 10.03 Cap/Depr(3y) 122.15%
Cap/Depr(5y) 109.78% Profit Quality(3y) N/A
Profit Quality(5y) N/A

Growth
EPS 1Y -88.24% EPS 3Y N/A
EPS 5Y -61.4% EPS growth Q2Q -114.04%
EPS Next Y -103.96% EPS Next 2Y -89.89%
EPS Next 3Y -37.98% EPS Next 5Y -8.02%
Revenue growth 1Y -59.23% Revenue growth 3Y 45.14%
Revenue growth 5Y 21.94% Revenue growth Q2Q -57.93%
Revenue Next Year -52.06% Revenue Next 2Y -42.72%
Revenue Next 3Y -23.89% Revenue Next 5Y -0.53%
EBIT growth 1Y -77.26% EBIT growth 3Y 90.47%
EBIT growth 5Y 27.95% EBIT Next Year -96.8%
EBIT Next 3Y -36% EBIT Next 5Y N/A
FCF growth 1Y 388.28% FCF growth 3Y 77.36%
FCF growth 5Y N/A OCF growth 1Y 395.7%
OCF growth 3Y 75.56% OCF growth 5Y N/A

Fundamental Stock Screener Links

Screen Image

Fundamental Stock Screener

Find stocks with similar Fundamental rating on the USA

Screen Image

Best Fundamental Competitors Stock Screener

Find the competitors with the best fundamentals on the USA

Screen Image

Best Valuation Competitors Stock Screener

Find the competitors with the best valuation on the USA

Screen Image

Best Dividend Competitors Stock Screener

Find the competitors with the best dividend on the USA